Preoperative prediction of the lymphovascular tumor thrombus of colorectal cancer with the iodine concentrations from dual-energy spectral CT

Xiang Yuan, Xin Quan, Xiao-ling Che, Lu-Lu Xu, Chun-mei Yang, Xiao-di Zhang, Jian ShuBmc Medical Imaging 2023 · DOI

TL;DR

This study explores the use of dual-energy spectral CT (DESCT) to predict lymphovascular tumor thrombus (LVTT) in colorectal cancer (CRC) patients before surgery. They found that the venous phase iodine concentration (NIC-VP) from DESCT can significantly differentiate between patients with and without LVTT, offering a promising non-invasive tool for treatment planning and prognosis.

What Problem Does This Paper Address?

Colorectal cancer (CRC) remains a significant health concern, with a substantial portion of patients presenting with metastasis. Lymphovascular tumor thrombus (LVTT) is a critical indicator of poor prognosis, associated with increased risk of lymph node metastasis, distant spread, and recurrence. The current gold standard for diagnosing LVTT is histopathological examination (hematoxylin-eosin staining) of surgical specimens. However, this method can be subjective and prone to inter-observer variability, potentially leading to false negatives. There's a clear need for accurate, non-invasive preoperative methods to identify LVTT, which would enable better treatment stratification and improve patient outcomes.

Methods

The researchers retrospectively analyzed abdominal DESCT scans from 50 pathologically confirmed CRC patients who had not received any preoperative treatment. They employed a dual-energy spectral CT protocol, which allows for the acquisition of spectral information beyond conventional CT. Key quantitative parameters extracted from the primary tumors in both arterial (AP) and venous (VP) phases included:

  • Normalized Iodine Concentration (NIC): This measures the iodine uptake in the tumor relative to the abdominal aorta or iliac vessels, reflecting blood flow and vessel permeability.
  • Effective Atomic Number (Zeff): This parameter provides information about the material composition of tissues.
  • Virtual Monochromatic Images (VMIs): These are reconstructed images at various energy levels (40-90 keV) to optimize tissue contrast.

Two experienced radiologists independently delineated regions of interest (ROIs) on the tumor and major vessels, avoiding necrotic areas and other non-tumor tissues. The study used SPSS 17.0 for statistical analysis, including t-tests for normally distributed data and receiver operating characteristic (ROC) curve analysis to assess diagnostic performance. Intra- and inter-observer agreement was evaluated using intraclass correlation coefficients (ICCs) to ensure the reliability of the measurements.

Datasets

The study utilized a dataset of 50 pathologically confirmed colorectal cancer patients who underwent abdominal DESCT prior to any treatment. These patients were recruited from October 2020 to August 2021. The dataset was divided into two groups based on histopathological findings: those with lymphovascular tumor thrombus (n=16) and those without (n=34).

Key Insights and Ideas

  • Venous Phase Iodine Concentration is Key: The study's most significant finding is the strong association between venous phase NIC (NIC-VP) and the presence of LVTT. This suggests that iodine accumulation in the venous phase, potentially reflecting slower clearance or retention of contrast within tumor-associated vessels, is a more sensitive indicator of LVTT than arterial phase measurements.
  • DESCT Offers Quantitative Advantage: Unlike conventional CT, DESCT provides quantitative parameters like NIC, which can offer objective insights into tumor microvasculature and lymphatic involvement. This moves beyond subjective visual assessment.
  • Potential for Non-Invasive Prediction: The ability to predict LVTT preoperatively using DESCT could significantly impact clinical decision-making, potentially guiding surgical approaches and adjuvant therapy selection without the need for invasive procedures or relying solely on subjective histopathology.

Key Results

  • The NIC-VP value was significantly higher in the lymphovascular tumor thrombus positive group (0.51 ± 0.13) compared to the negative group (0.43 ± 0.12) (p = 0.039).
  • No significant difference was found in NIC-AP values between the two groups (p = 0.423).
  • The ROC analysis identified an optimal threshold value of 0.364 for NIC-VP to predict LVTT, achieving a sensitivity of 68.8% and a specificity of 67.6%.
  • Other DESCT parameters like Zeff and VMI values did not show significant associations with LVTT in this study.
  • Inter-observer agreement for NIC measurements was found to be "very well" to "excellent," indicating the reliability of the quantitative analysis.

Limitations and Future Work

The authors acknowledge several limitations:

  • Small Sample Size: The study included only 50 patients, which they note is a limitation for generalizing the findings.
  • Single-Center Study: The data was collected from a single institution, which may limit the generalizability of the results.
  • ROI Limitations: Selecting ROIs in specific tumor regions may not fully represent the iodine concentration of the entire tumor focus.

Future work should focus on multicenter studies with larger sample sizes to validate these findings and establish more robust diagnostic criteria. Further research could also explore the integration of DESCT parameters with other imaging modalities or clinical data for a more comprehensive preoperative assessment of LVTT and its prognostic implications.

Summary updated

BibTeX
@article{yuan2023preoperative,
  author = {Xiang Yuan and Xin Quan and Xiao-ling Che and Lu-Lu Xu and Chun-mei Yang and Xiao-di Zhang and Jian Shu},
  title = {{Preoperative prediction of the lymphovascular tumor thrombus of colorectal cancer with the iodine concentrations from dual-energy spectral CT}},
  journal = {Bmc Medical Imaging},
  year = {2023},
  doi = {10.1186/s12880-023-01060-z},
}
Figure